Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 7, 2004
Grant Date -
May 9, 2002
app pub date -
Feb 2, 1999
filing date -
Mar 31, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A monoclonal antibody is provided which is directed against the human interferon type I receptor (IFN-R), which recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. Diagnostic and therapeutic applications for the monoclonal antibody also are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully